Bartlett Doesn't Bar Darvocet Defect Claims, 6th Circ. Told

By Sindhu Sundar ( May 8, 2014, 8:54 PM EDT) -- The plaintiffs in multidistrict litigation over injuries allegedly caused by generic versions of the painkillers Darvocet and Darvon told the Sixth Circuit on Wednesday that the U.S. Supreme Court's Bartlett decision does not impede them from succeeding on state design defect claims over allegedly misbranded drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!